Rhumbline Advisers Sells 3,768 Shares of Proto Labs, Inc. $PRLB

Rhumbline Advisers cut its position in Proto Labs, Inc. (NYSE:PRLB) by 4.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 75,015 shares of the industrial products company’s stock after selling 3,768 shares during the quarter. Rhumbline Advisers owned about 0.32% of Proto Labs worth $2,629,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in PRLB. Wellington Management Group LLP grew its position in shares of Proto Labs by 97.4% in the first quarter. Wellington Management Group LLP now owns 711,738 shares of the industrial products company’s stock valued at $24,939,000 after purchasing an additional 351,097 shares in the last quarter. Pacer Advisors Inc. grew its position in shares of Proto Labs by 9,033.1% in the first quarter. Pacer Advisors Inc. now owns 148,595 shares of the industrial products company’s stock valued at $5,207,000 after purchasing an additional 146,968 shares in the last quarter. Nuveen LLC purchased a new position in shares of Proto Labs in the first quarter valued at $2,458,000. Algert Global LLC grew its position in shares of Proto Labs by 137.3% in the first quarter. Algert Global LLC now owns 85,084 shares of the industrial products company’s stock valued at $2,981,000 after purchasing an additional 49,230 shares in the last quarter. Finally, Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in shares of Proto Labs in the first quarter valued at $1,336,000. 84.54% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, CEO Suresh Krishna acquired 1,725 shares of the business’s stock in a transaction dated Monday, August 4th. The stock was purchased at an average cost of $43.51 per share, for a total transaction of $75,054.75. Following the acquisition, the chief executive officer owned 18,021 shares of the company’s stock, valued at $784,093.71. This trade represents a 10.59% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders own 1.20% of the company’s stock.

Proto Labs Trading Down 0.5%

PRLB opened at $49.42 on Wednesday. The stock has a 50-day moving average price of $45.55 and a 200-day moving average price of $40.15. Proto Labs, Inc. has a 12-month low of $26.34 and a 12-month high of $51.09. The stock has a market capitalization of $1.18 billion, a P/E ratio of 82.37 and a beta of 1.27.

Proto Labs (NYSE:PRLB) last posted its quarterly earnings data on Thursday, July 31st. The industrial products company reported $0.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.33 by $0.08. Proto Labs had a return on equity of 2.22% and a net margin of 2.91%.The firm had revenue of $135.06 million during the quarter, compared to analysts’ expectations of $128.05 million. During the same period in the prior year, the business earned $0.38 EPS. The company’s revenue for the quarter was up 7.6% compared to the same quarter last year. Proto Labs has set its Q3 2025 guidance at 0.350-0.430 EPS. On average, equities research analysts predict that Proto Labs, Inc. will post 0.81 EPS for the current year.

Analyst Ratings Changes

PRLB has been the subject of several recent analyst reports. Cantor Fitzgerald boosted their target price on Proto Labs from $50.00 to $51.00 and gave the stock an “overweight” rating in a research report on Friday, August 1st. Craig Hallum upgraded Proto Labs from a “hold” rating to a “buy” rating and set a $54.00 target price for the company in a research report on Friday, August 1st. Finally, Wall Street Zen upgraded Proto Labs from a “buy” rating to a “strong-buy” rating in a research report on Saturday, August 2nd. Two analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $52.50.

Proto Labs Profile

Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.